Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
114.54
-1.35 (-1.16%)
Jun 5, 2025, 3:00 PM CST
SHA:688266 Revenue
Suzhou Zelgen Biopharmaceuticals had revenue of 167.64M CNY in the quarter ending March 31, 2025, with 54.87% growth. This brings the company's revenue in the last twelve months to 592.35M, up 53.23% year-over-year. In the year 2024, Suzhou Zelgen Biopharmaceuticals had annual revenue of 532.95M with 37.91% growth.
Revenue (ttm)
592.35M
Revenue Growth
+53.23%
P/S Ratio
51.19
Revenue / Employee
650.94K
Employees
910
Market Cap
30.32B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |